CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the company and its collaborators will present 20 oral and poster presentations at the 2015 United States & Canadian Academy of Pathology (USCAP) Annual Meeting taking place March 21-27, 2015 in Boston. The company’s molecular information products, FoundationOne® for solid tumors and FoundationOne® Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient’s cancer.
Help employers find you! Check out all the jobs and post your resume.
